Ana Alarcón Tomás

Hospital Universitario Puerta de Hierro Majadahonda

MedicineEngineeringAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation”.

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

New England Journal of Medicine(2020)10.1056/nejmoa1900623

N/A

0.995DataRank · unranked

757 citations

Antonio L. C. Gomes, Sean M. Devlin, Eric R. Littmann, Ying Taur, Anthony D. Sung +47 more

Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients

European Heart Journal(2023)10.1093/eurheartj/ehad117

N/A

0.590DataRank · unranked

50 citations

Peter A. Riedell, Stephanie Feldman, Gina George, Stephen Sansoterra, Thomas Althaus +29 more

Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.08.001

N/A

0.496DataRank · unranked

9 citations

Ana Alarcón Tomás, Jessica Flynn, Joshua Fein, Anna Alperovich, Theodora Anagnostou +19 more

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010003

N/A

0.470DataRank · unranked

22 citations

Soo‐Jeong Kim, Samantha Brown, Theresa A. Elko, Josel D. Ruiz, Danielle M Hanley +19 more

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

Blood Advances(2022)10.1182/bloodadvances.2022008937

N/A

0DataRank · unranked

20 citations

Vivek Patel, David L. Porter, Stephen J. Schuster, Loretta J. Nastoupil, Miguel‐Angel Perales +10 more

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

Nature Medicine(2023)10.1038/s41591-023-02404-6

N/A

0DataRank · unranked

167 citations

Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah +14 more

EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation(2023)10.1038/s41409-023-01922-8

N/A

0DataRank · unranked

39 citations

Jessica Flynn, Sean M. Devlin, Molly Maloy, Samira Fatmi, Ana Alarcón Tomás +7 more

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010302

N/A

0DataRank · unranked

35 citations

Jessica Flynn, Mithat Gönen, Sean M. Devlin, Allison Parascondola, Ana Alarcón Tomás +17 more

Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01540-x

N/A

0DataRank · unranked

39 citations

Jessica Flynn, Sean M. Devlin, Audrey Mauguen, Teng Fei, Shang Zeng +23 more

Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.027

N/A

0DataRank · unranked

13 citations

Roni Shouval, Jessica Flynn, Sean M. Devlin, Amethyst Saldia, Alejandro Luna +16 more

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01273-1

N/A

0DataRank · unranked

4 citations

Sean M. Devlin, Kai Rejeski, Jessica Flynn, Magdalena Corona, Efrat Luttwak +21 more

Antibody Titers of Vaccine-Preventable Pathogens at 1 Year Post CD19 CAR-T Cell Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.10.034

N/A

0DataRank · unranked

0 citations

Nishi Shah, Sigrun Einarsdottir, Ana Alarcón Tomás, Meighan Palazzo, Josel D. Ruiz +11 more

Patterns and safety of glucocorticosteroid use following CD19 CAR‐T therapy for large B‐cell lymphoma

HemaSphere(2025)10.1002/hem3.70248

N/A

0DataRank · unranked

0 citations

David Nemirovsky, Sean M. Devlin, Alexander P. Boardman, Giulio Cassanello, Magdalena Corona +19 more

The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant

Bone Marrow Transplantation(2021)10.1038/s41409-021-01392-w

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Molly Maloy, Josel D. Ruiz, Sean M. Devlin, Miriam Sánchez‐Escamilla +11 more

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

Blood Advances(2022)10.1182/bloodadvances.2022008294

N/A

0DataRank · unranked

42 citations

Ana Alarcón Tomás, Jessica Flynn, Sean M. Devlin, Jamie Brower, Veronika Bachanová +10 more

Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.10.026

N/A

0DataRank · unranked

26 citations

Roni Shouval, Moneeza Walji, Jessica Flynn, Ronit Yerushalmi, Noga Shem‐Tov +16 more